| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Angiography | 24 | 2001 | 186 | 1.960 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2001 | 2250 | 1.080 |
Why?
|
| Angiography | 13 | 2000 | 154 | 0.730 |
Why?
|
| Tomography, X-Ray Computed | 22 | 2009 | 1659 | 0.710 |
Why?
|
| Femoral Artery | 7 | 2001 | 104 | 0.690 |
Why?
|
| Embolization, Therapeutic | 9 | 2019 | 335 | 0.630 |
Why?
|
| Aortic Aneurysm | 8 | 2005 | 81 | 0.590 |
Why?
|
| Heart Defects, Congenital | 7 | 1999 | 101 | 0.580 |
Why?
|
| Contrast Media | 12 | 2003 | 432 | 0.570 |
Why?
|
| Angioplasty, Balloon | 7 | 1999 | 55 | 0.560 |
Why?
|
| Coronary Disease | 8 | 1998 | 246 | 0.540 |
Why?
|
| Stents | 8 | 1999 | 500 | 0.540 |
Why?
|
| Angiography, Digital Subtraction | 11 | 2003 | 139 | 0.520 |
Why?
|
| Coronary Angiography | 14 | 2002 | 212 | 0.510 |
Why?
|
| Punctures | 7 | 2001 | 62 | 0.500 |
Why?
|
| Catheterization | 7 | 2001 | 111 | 0.500 |
Why?
|
| Humans | 149 | 2019 | 65463 | 0.490 |
Why?
|
| Arteriovenous Malformations | 7 | 1997 | 45 | 0.480 |
Why?
|
| Ultrasonography | 18 | 2000 | 491 | 0.470 |
Why?
|
| Pulmonary Veins | 7 | 1998 | 35 | 0.440 |
Why?
|
| Aorta, Thoracic | 9 | 1999 | 80 | 0.440 |
Why?
|
| Thrombolytic Therapy | 4 | 2004 | 197 | 0.430 |
Why?
|
| Catheterization, Central Venous | 5 | 1996 | 84 | 0.420 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2002 | 23 | 0.410 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2000 | 67 | 0.410 |
Why?
|
| Urokinase-Type Plasminogen Activator | 3 | 2004 | 13 | 0.400 |
Why?
|
| Radiography, Interventional | 6 | 1998 | 83 | 0.380 |
Why?
|
| Aortic Aneurysm, Thoracic | 6 | 2001 | 109 | 0.380 |
Why?
|
| Plasminogen Activators | 2 | 2004 | 10 | 0.370 |
Why?
|
| Popliteal Artery | 3 | 1999 | 24 | 0.370 |
Why?
|
| Catheterization, Peripheral | 5 | 1999 | 51 | 0.360 |
Why?
|
| Heart Diseases | 6 | 1999 | 223 | 0.330 |
Why?
|
| Vascular Diseases | 5 | 1997 | 83 | 0.330 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2004 | 46 | 0.330 |
Why?
|
| Cardiac Catheterization | 6 | 1996 | 292 | 0.320 |
Why?
|
| Diagnostic Imaging | 4 | 2000 | 272 | 0.320 |
Why?
|
| Echocardiography | 7 | 2000 | 513 | 0.300 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2000 | 699 | 0.290 |
Why?
|
| Angiocardiography | 3 | 1994 | 6 | 0.280 |
Why?
|
| Pulmonary Artery | 6 | 1999 | 96 | 0.280 |
Why?
|
| Chemoembolization, Therapeutic | 4 | 2003 | 10 | 0.270 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2001 | 228 | 0.270 |
Why?
|
| Ischemia | 7 | 2000 | 203 | 0.250 |
Why?
|
| Foreign-Body Migration | 2 | 1997 | 24 | 0.250 |
Why?
|
| Heart Injuries | 2 | 1998 | 19 | 0.240 |
Why?
|
| Aortic Diseases | 5 | 1997 | 65 | 0.240 |
Why?
|
| Hepatic Artery | 3 | 2003 | 22 | 0.230 |
Why?
|
| Heart Atria | 3 | 2002 | 137 | 0.230 |
Why?
|
| Catheters, Indwelling | 3 | 2003 | 67 | 0.230 |
Why?
|
| Radiography, Thoracic | 4 | 1995 | 117 | 0.220 |
Why?
|
| Foreign Bodies | 3 | 1995 | 56 | 0.220 |
Why?
|
| Thorax | 2 | 1995 | 35 | 0.210 |
Why?
|
| Carotid Artery Diseases | 4 | 1994 | 61 | 0.210 |
Why?
|
| Middle Aged | 43 | 2019 | 18387 | 0.200 |
Why?
|
| United States Food and Drug Administration | 2 | 2004 | 92 | 0.200 |
Why?
|
| Sensitivity and Specificity | 9 | 2000 | 1170 | 0.200 |
Why?
|
| Radiography | 11 | 1999 | 558 | 0.200 |
Why?
|
| Diabetic Angiopathies | 2 | 2000 | 29 | 0.200 |
Why?
|
| Male | 53 | 2019 | 31187 | 0.200 |
Why?
|
| Liver Neoplasms | 3 | 2003 | 308 | 0.190 |
Why?
|
| Hematoma | 2 | 2001 | 85 | 0.190 |
Why?
|
| Vascular Fistula | 1 | 2002 | 8 | 0.190 |
Why?
|
| Radiology, Interventional | 2 | 2009 | 31 | 0.180 |
Why?
|
| Radiographic Image Enhancement | 5 | 1999 | 99 | 0.180 |
Why?
|
| Angioplasty, Laser | 2 | 1991 | 2 | 0.170 |
Why?
|
| Echocardiography, Transesophageal | 3 | 1998 | 117 | 0.170 |
Why?
|
| Cardiovascular Diseases | 5 | 2000 | 867 | 0.170 |
Why?
|
| Pulmonary Embolism | 2 | 2004 | 196 | 0.160 |
Why?
|
| Portal Vein | 6 | 2001 | 39 | 0.160 |
Why?
|
| Leg | 5 | 2000 | 87 | 0.160 |
Why?
|
| Phlebography | 7 | 1995 | 45 | 0.160 |
Why?
|
| Vascular Patency | 6 | 2003 | 135 | 0.160 |
Why?
|
| Drug Approval | 1 | 2000 | 28 | 0.160 |
Why?
|
| Myocardium | 4 | 1994 | 302 | 0.160 |
Why?
|
| Penis | 3 | 1988 | 37 | 0.160 |
Why?
|
| Cardiomyopathies | 3 | 1999 | 137 | 0.160 |
Why?
|
| Iliac Artery | 3 | 1999 | 43 | 0.150 |
Why?
|
| Heart | 4 | 1994 | 298 | 0.150 |
Why?
|
| Aorta, Abdominal | 5 | 1995 | 56 | 0.150 |
Why?
|
| Polyvinyls | 1 | 2019 | 19 | 0.150 |
Why?
|
| Neuroendocrine Tumors | 1 | 1999 | 20 | 0.150 |
Why?
|
| Urinary Fistula | 1 | 2019 | 17 | 0.150 |
Why?
|
| Carotid Stenosis | 2 | 1998 | 100 | 0.150 |
Why?
|
| Thrombosis | 5 | 1996 | 206 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 2 | 1994 | 190 | 0.150 |
Why?
|
| Lidocaine | 1 | 1999 | 33 | 0.150 |
Why?
|
| Electrodes, Implanted | 2 | 1997 | 38 | 0.150 |
Why?
|
| Vena Cava, Inferior | 2 | 1998 | 34 | 0.150 |
Why?
|
| Ureter | 1 | 2019 | 37 | 0.150 |
Why?
|
| Urinary Incontinence | 1 | 2019 | 45 | 0.150 |
Why?
|
| Adult | 29 | 2001 | 17461 | 0.140 |
Why?
|
| Duodenum | 1 | 1999 | 41 | 0.140 |
Why?
|
| Anesthetics, Local | 1 | 1999 | 73 | 0.140 |
Why?
|
| Appointments and Schedules | 1 | 1999 | 60 | 0.140 |
Why?
|
| Stomach | 1 | 1999 | 87 | 0.140 |
Why?
|
| Veins | 7 | 1997 | 63 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1999 | 88 | 0.140 |
Why?
|
| Myocardial Ischemia | 2 | 1999 | 121 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2001 | 741 | 0.140 |
Why?
|
| Wounds, Penetrating | 1 | 1998 | 33 | 0.140 |
Why?
|
| Kidney Diseases | 2 | 1992 | 178 | 0.130 |
Why?
|
| Aged | 27 | 2019 | 15052 | 0.130 |
Why?
|
| Calcinosis | 1 | 1998 | 84 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 1996 | 267 | 0.130 |
Why?
|
| Equipment Design | 6 | 1996 | 371 | 0.130 |
Why?
|
| Metals | 1 | 1997 | 65 | 0.130 |
Why?
|
| Palliative Care | 1 | 2019 | 250 | 0.120 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1996 | 5 | 0.120 |
Why?
|
| Coronary Artery Bypass | 2 | 2002 | 292 | 0.120 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1996 | 28 | 0.120 |
Why?
|
| Female | 38 | 2019 | 34193 | 0.120 |
Why?
|
| Pain | 1 | 1999 | 400 | 0.120 |
Why?
|
| Pericarditis, Constrictive | 1 | 1996 | 3 | 0.120 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 1996 | 9 | 0.120 |
Why?
|
| Bile Duct Neoplasms | 1 | 1996 | 59 | 0.120 |
Why?
|
| Azygos Vein | 1 | 1995 | 4 | 0.120 |
Why?
|
| Heart Valve Prosthesis | 1 | 1997 | 106 | 0.120 |
Why?
|
| Computers | 1 | 1995 | 49 | 0.110 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2002 | 115 | 0.110 |
Why?
|
| Renal Artery Obstruction | 4 | 1995 | 17 | 0.110 |
Why?
|
| Fistula | 2 | 1995 | 14 | 0.110 |
Why?
|
| Retrospective Studies | 11 | 2019 | 6929 | 0.110 |
Why?
|
| Hemochromatosis | 1 | 1994 | 8 | 0.110 |
Why?
|
| Ebstein Anomaly | 1 | 1994 | 5 | 0.110 |
Why?
|
| Cerebrovascular Disorders | 3 | 1990 | 83 | 0.110 |
Why?
|
| Erectile Dysfunction | 3 | 1988 | 28 | 0.110 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1994 | 13 | 0.100 |
Why?
|
| Castleman Disease | 1 | 1994 | 4 | 0.100 |
Why?
|
| Mediastinal Diseases | 1 | 1994 | 15 | 0.100 |
Why?
|
| Heart Neoplasms | 1 | 1994 | 36 | 0.100 |
Why?
|
| Gallium Radioisotopes | 1 | 1993 | 15 | 0.100 |
Why?
|
| Heart Septal Defects | 1 | 1993 | 2 | 0.100 |
Why?
|
| Kidney | 5 | 2000 | 455 | 0.100 |
Why?
|
| Pericarditis | 1 | 1993 | 10 | 0.100 |
Why?
|
| Subclavian Artery | 1 | 1993 | 26 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2019 | 5806 | 0.100 |
Why?
|
| Abdomen | 1 | 1993 | 97 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1997 | 271 | 0.100 |
Why?
|
| Mammary Arteries | 2 | 1993 | 11 | 0.100 |
Why?
|
| Vasodilator Agents | 3 | 2000 | 70 | 0.100 |
Why?
|
| Coronary Thrombosis | 1 | 1993 | 21 | 0.100 |
Why?
|
| Aneurysm | 1 | 1993 | 58 | 0.100 |
Why?
|
| Melanoma | 1 | 1996 | 333 | 0.090 |
Why?
|
| Pancreatic Diseases | 1 | 1992 | 38 | 0.090 |
Why?
|
| Pericardial Effusion | 1 | 1992 | 22 | 0.090 |
Why?
|
| Diatrizoate | 2 | 1989 | 4 | 0.090 |
Why?
|
| Software | 1 | 1995 | 401 | 0.090 |
Why?
|
| Dipyridamole | 3 | 1996 | 17 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 3 | 2003 | 21 | 0.090 |
Why?
|
| Equipment Failure | 3 | 1996 | 69 | 0.090 |
Why?
|
| Brachial Artery | 1 | 1991 | 27 | 0.090 |
Why?
|
| Electrocardiography | 5 | 2000 | 555 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 1991 | 54 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 1993 | 160 | 0.080 |
Why?
|
| Mesenteric Arteries | 2 | 1987 | 10 | 0.080 |
Why?
|
| Urinary Bladder | 2 | 1987 | 48 | 0.080 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 5644 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 1996 | 990 | 0.080 |
Why?
|
| Lung | 2 | 1997 | 967 | 0.080 |
Why?
|
| Brain Abscess | 1 | 1990 | 7 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 1990 | 50 | 0.080 |
Why?
|
| Body Burden | 1 | 2009 | 12 | 0.080 |
Why?
|
| Thoracic Arteries | 1 | 1989 | 3 | 0.070 |
Why?
|
| Radiometry | 1 | 2009 | 39 | 0.070 |
Why?
|
| Radiation Protection | 1 | 2009 | 27 | 0.070 |
Why?
|
| Urinary Catheterization | 2 | 1987 | 20 | 0.070 |
Why?
|
| Aortitis | 3 | 1993 | 5 | 0.070 |
Why?
|
| Carotid Arteries | 1 | 1989 | 64 | 0.070 |
Why?
|
| Aminopyrine | 1 | 1988 | 1 | 0.070 |
Why?
|
| Dipyrone | 1 | 1988 | 1 | 0.070 |
Why?
|
| Butylscopolammonium Bromide | 1 | 1988 | 2 | 0.070 |
Why?
|
| Parasympatholytics | 1 | 1988 | 7 | 0.070 |
Why?
|
| Ventricular Fibrillation | 1 | 1989 | 108 | 0.070 |
Why?
|
| Pulmonary Emphysema | 1 | 1989 | 109 | 0.070 |
Why?
|
| Scopolamine Derivatives | 1 | 1988 | 14 | 0.070 |
Why?
|
| Urinary Bladder Diseases | 1 | 1987 | 10 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 1998 | 48 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 465 | 0.060 |
Why?
|
| General Surgery | 1 | 1989 | 210 | 0.060 |
Why?
|
| Hypertension, Renovascular | 1 | 1986 | 6 | 0.060 |
Why?
|
| Diagnostic Errors | 2 | 2000 | 106 | 0.060 |
Why?
|
| United States | 4 | 2004 | 8148 | 0.060 |
Why?
|
| Deglutition | 1 | 2006 | 20 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 1993 | 921 | 0.060 |
Why?
|
| Femoral Vein | 2 | 1996 | 20 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2006 | 44 | 0.060 |
Why?
|
| Prospective Studies | 7 | 1999 | 3324 | 0.060 |
Why?
|
| Intestines | 1 | 1987 | 182 | 0.060 |
Why?
|
| Radiology | 1 | 1989 | 263 | 0.060 |
Why?
|
| Length of Stay | 2 | 1999 | 828 | 0.060 |
Why?
|
| Drainage | 1 | 1985 | 153 | 0.050 |
Why?
|
| Motion Pictures | 2 | 1994 | 11 | 0.050 |
Why?
|
| Radionuclide Imaging | 2 | 1994 | 129 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 1995 | 1431 | 0.050 |
Why?
|
| Cardiac Output | 2 | 1996 | 29 | 0.050 |
Why?
|
| Drug and Narcotic Control | 1 | 2004 | 27 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 3 | 1993 | 105 | 0.050 |
Why?
|
| Carotid Artery, Internal | 2 | 1997 | 69 | 0.050 |
Why?
|
| Aortography | 2 | 1993 | 58 | 0.050 |
Why?
|
| Behcet Syndrome | 2 | 2001 | 4 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2004 | 126 | 0.050 |
Why?
|
| Pentetic Acid | 3 | 1996 | 33 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2005 | 240 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 1985 | 325 | 0.050 |
Why?
|
| Fluoroscopy | 2 | 2006 | 69 | 0.040 |
Why?
|
| Organometallic Compounds | 3 | 1996 | 71 | 0.040 |
Why?
|
| Retroperitoneal Space | 1 | 2001 | 23 | 0.040 |
Why?
|
| Ligaments | 1 | 2001 | 9 | 0.040 |
Why?
|
| Liver Abscess | 1 | 2001 | 18 | 0.040 |
Why?
|
| Observer Variation | 3 | 2002 | 216 | 0.040 |
Why?
|
| Contraindications | 2 | 1999 | 52 | 0.040 |
Why?
|
| Heart Valve Diseases | 2 | 1999 | 93 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2001 | 90 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 1999 | 289 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2001 | 113 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 1985 | 389 | 0.040 |
Why?
|
| Time Factors | 3 | 2019 | 3774 | 0.040 |
Why?
|
| Gadolinium DTPA | 3 | 2000 | 84 | 0.040 |
Why?
|
| Drug Industry | 1 | 2000 | 41 | 0.040 |
Why?
|
| Myocarditis | 1 | 2000 | 71 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 1997 | 1334 | 0.040 |
Why?
|
| Posture | 1 | 2000 | 128 | 0.040 |
Why?
|
| Postoperative Period | 1 | 1999 | 130 | 0.040 |
Why?
|
| Pericardium | 1 | 1999 | 35 | 0.040 |
Why?
|
| Artifacts | 1 | 2000 | 128 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2000 | 181 | 0.040 |
Why?
|
| Foot | 1 | 1999 | 42 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 1999 | 223 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1998 | 25 | 0.030 |
Why?
|
| Subclavian Vein | 2 | 1995 | 13 | 0.030 |
Why?
|
| Vena Cava, Superior | 2 | 1995 | 9 | 0.030 |
Why?
|
| Lung Diseases | 2 | 1997 | 183 | 0.030 |
Why?
|
| Endarterectomy, Carotid | 1 | 1998 | 79 | 0.030 |
Why?
|
| Pain Measurement | 1 | 1999 | 343 | 0.030 |
Why?
|
| Brachiocephalic Trunk | 1 | 1997 | 15 | 0.030 |
Why?
|
| Hospital Costs | 1 | 1998 | 126 | 0.030 |
Why?
|
| Hemosiderosis | 1 | 1997 | 2 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1997 | 60 | 0.030 |
Why?
|
| Cyanosis | 1 | 1997 | 7 | 0.030 |
Why?
|
| Survival Rate | 1 | 1999 | 847 | 0.030 |
Why?
|
| Cerebellar Diseases | 1 | 1997 | 9 | 0.030 |
Why?
|
| Ossification, Heterotopic | 1 | 1997 | 14 | 0.030 |
Why?
|
| Child | 4 | 1991 | 4623 | 0.030 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 1997 | 20 | 0.030 |
Why?
|
| Vertebral Artery | 1 | 1997 | 29 | 0.030 |
Why?
|
| Aneurysm, False | 2 | 1994 | 47 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 1996 | 11 | 0.030 |
Why?
|
| Neoplasms | 2 | 1999 | 1372 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1996 | 10 | 0.030 |
Why?
|
| Heart Valves | 1 | 1996 | 26 | 0.030 |
Why?
|
| Headache | 1 | 1997 | 58 | 0.030 |
Why?
|
| Rotation | 1 | 1996 | 26 | 0.030 |
Why?
|
| Safety | 1 | 1997 | 142 | 0.030 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1996 | 3 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 1997 | 85 | 0.030 |
Why?
|
| Ascites | 1 | 1996 | 22 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1996 | 50 | 0.030 |
Why?
|
| Portal System | 1 | 1996 | 3 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 1997 | 99 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 1998 | 310 | 0.030 |
Why?
|
| Mitral Valve | 1 | 1997 | 126 | 0.030 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 1995 | 9 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2000 | 2188 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 2776 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1995 | 41 | 0.030 |
Why?
|
| Surface Properties | 1 | 1996 | 283 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 1999 | 367 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 2 | 1997 | 215 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1995 | 77 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 1999 | 354 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 1995 | 28 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 1710 | 0.030 |
Why?
|
| Cineangiography | 1 | 1994 | 2 | 0.030 |
Why?
|
| Thallium Radioisotopes | 1 | 1994 | 9 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 1995 | 127 | 0.030 |
Why?
|
| Treatment Failure | 1 | 1995 | 208 | 0.030 |
Why?
|
| Image Enhancement | 1 | 1996 | 193 | 0.030 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1994 | 34 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2000 | 1564 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 1996 | 74 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 1995 | 1114 | 0.030 |
Why?
|
| Regional Blood Flow | 3 | 1996 | 116 | 0.030 |
Why?
|
| Fetal Heart | 1 | 1994 | 5 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 1994 | 34 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 1994 | 30 | 0.030 |
Why?
|
| Esophagus | 1 | 1994 | 47 | 0.030 |
Why?
|
| Bronchial Arteries | 1 | 1993 | 3 | 0.030 |
Why?
|
| Fever of Unknown Origin | 1 | 1993 | 4 | 0.030 |
Why?
|
| Vascular Resistance | 2 | 1991 | 47 | 0.030 |
Why?
|
| Hemoptysis | 1 | 1993 | 10 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 1994 | 40 | 0.030 |
Why?
|
| Thoracotomy | 1 | 1994 | 47 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 1994 | 133 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1994 | 63 | 0.020 |
Why?
|
| Heart Septum | 1 | 1993 | 57 | 0.020 |
Why?
|
| Ultrasonics | 1 | 1993 | 19 | 0.020 |
Why?
|
| Drug Combinations | 2 | 1996 | 166 | 0.020 |
Why?
|
| Legionellosis | 1 | 1993 | 1 | 0.020 |
Why?
|
| Exercise Test | 1 | 1994 | 257 | 0.020 |
Why?
|
| Pregnancy | 2 | 1994 | 2390 | 0.020 |
Why?
|
| Pericardial Window Techniques | 1 | 1992 | 1 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 1993 | 125 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 1993 | 78 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1992 | 32 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 491 | 0.020 |
Why?
|
| Iron | 1 | 1993 | 155 | 0.020 |
Why?
|
| Bacteremia | 1 | 1993 | 91 | 0.020 |
Why?
|
| Acute Disease | 2 | 1992 | 663 | 0.020 |
Why?
|
| Pancreas | 1 | 1992 | 153 | 0.020 |
Why?
|
| Subtraction Technique | 2 | 1988 | 24 | 0.020 |
Why?
|
| Metoclopramide | 1 | 1991 | 12 | 0.020 |
Why?
|
| Urination | 2 | 1987 | 16 | 0.020 |
Why?
|
| Coronary Aneurysm | 1 | 1990 | 7 | 0.020 |
Why?
|
| Blood Pressure | 2 | 1991 | 535 | 0.020 |
Why?
|
| England | 1 | 1990 | 28 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1990 | 51 | 0.020 |
Why?
|
| Emphysema | 1 | 1990 | 38 | 0.020 |
Why?
|
| Pneumothorax | 1 | 1990 | 49 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1990 | 106 | 0.020 |
Why?
|
| Iopamidol | 1 | 1989 | 13 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 1990 | 60 | 0.020 |
Why?
|
| Adolescent | 2 | 1990 | 6332 | 0.020 |
Why?
|
| Risk Factors | 1 | 2000 | 5458 | 0.020 |
Why?
|
| Single-Blind Method | 2 | 2000 | 142 | 0.020 |
Why?
|
| North America | 1 | 2009 | 114 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 1989 | 56 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1994 | 787 | 0.020 |
Why?
|
| Renal Circulation | 1 | 1987 | 14 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1992 | 808 | 0.020 |
Why?
|
| Research Design | 1 | 1991 | 590 | 0.020 |
Why?
|
| Technetium | 1 | 1987 | 68 | 0.020 |
Why?
|
| Hospitals | 1 | 1990 | 397 | 0.020 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1987 | 12 | 0.020 |
Why?
|
| Prostatic Hyperplasia | 1 | 1987 | 35 | 0.020 |
Why?
|
| Viscera | 1 | 1986 | 10 | 0.020 |
Why?
|
| Celiac Artery | 1 | 1987 | 13 | 0.020 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 1986 | 27 | 0.020 |
Why?
|
| Enalapril | 1 | 1986 | 2 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2003 | 2492 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1985 | 30 | 0.010 |
Why?
|
| Prognosis | 1 | 1990 | 1789 | 0.010 |
Why?
|
| Video Recording | 1 | 2006 | 140 | 0.010 |
Why?
|
| Constriction, Pathologic | 2 | 1997 | 131 | 0.010 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1984 | 2 | 0.010 |
Why?
|
| Salicylates | 1 | 1984 | 8 | 0.010 |
Why?
|
| Acidosis | 1 | 1984 | 28 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1985 | 278 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 108 | 0.010 |
Why?
|
| Infant | 1 | 1989 | 1703 | 0.010 |
Why?
|
| Iodized Oil | 1 | 2003 | 2 | 0.010 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2003 | 3 | 0.010 |
Why?
|
| Polyvinyl Alcohol | 1 | 2003 | 11 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1989 | 2633 | 0.010 |
Why?
|
| Maryland | 1 | 2003 | 36 | 0.010 |
Why?
|
| Mitomycin | 1 | 2003 | 29 | 0.010 |
Why?
|
| Liver | 2 | 1999 | 871 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2003 | 38 | 0.010 |
Why?
|
| Hemostatics | 1 | 2003 | 27 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2003 | 98 | 0.010 |
Why?
|
| Cisplatin | 1 | 2003 | 145 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2001 | 16 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 857 | 0.010 |
Why?
|
| Life Tables | 1 | 1999 | 23 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 642 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 1997 | 96 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1996 | 13 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1996 | 7 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1996 | 10 | 0.010 |
Why?
|
| Patient Selection | 1 | 1999 | 484 | 0.010 |
Why?
|
| Meglumine | 1 | 1996 | 21 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1996 | 15 | 0.010 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1999 | 277 | 0.010 |
Why?
|
| Reoperation | 1 | 1996 | 307 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1994 | 28 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1996 | 181 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1996 | 157 | 0.010 |
Why?
|
| Recurrence | 1 | 1996 | 662 | 0.010 |
Why?
|
| Renal Artery | 1 | 1994 | 36 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1996 | 221 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1997 | 742 | 0.010 |
Why?
|
| Brachiocephalic Veins | 1 | 1993 | 5 | 0.010 |
Why?
|
| Venous Insufficiency | 1 | 1993 | 6 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1993 | 28 | 0.010 |
Why?
|
| Thumb | 1 | 1993 | 27 | 0.010 |
Why?
|
| Magnetics | 1 | 1993 | 53 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1993 | 199 | 0.010 |
Why?
|
| Aorta | 1 | 1992 | 108 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1989 | 37 | 0.000 |
Why?
|
| Systole | 1 | 1989 | 109 | 0.000 |
Why?
|
| Diastole | 1 | 1989 | 90 | 0.000 |
Why?
|
| Phentolamine | 1 | 1988 | 7 | 0.000 |
Why?
|
| Penile Erection | 1 | 1988 | 7 | 0.000 |
Why?
|
| Papaverine | 1 | 1988 | 7 | 0.000 |
Why?
|
| Radioisotope Renography | 1 | 1987 | 4 | 0.000 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1987 | 11 | 0.000 |
Why?
|
| Methods | 1 | 1987 | 40 | 0.000 |
Why?
|
| Microspheres | 1 | 1987 | 55 | 0.000 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1987 | 7 | 0.000 |
Why?
|
| Urine | 1 | 1987 | 47 | 0.000 |
Why?
|
| Dogs | 1 | 1987 | 315 | 0.000 |
Why?
|
| Marfan Syndrome | 1 | 1985 | 19 | 0.000 |
Why?
|
| Dichlorphenamide | 1 | 1984 | 1 | 0.000 |
Why?
|
| Acetazolamide | 1 | 1984 | 2 | 0.000 |
Why?
|
| Arthritis | 1 | 1984 | 52 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1984 | 126 | 0.000 |
Why?
|
| Glaucoma | 1 | 1984 | 68 | 0.000 |
Why?
|
| Aspirin | 1 | 1984 | 172 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1984 | 463 | 0.000 |
Why?
|
| Animals | 1 | 1987 | 21381 | 0.000 |
Why?
|